FibroGen Priced, Nasdaq: FGEN

Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca

Industry: Health Care

Latest Trade: $25.45 0.00 (0.0%)

First Day Return: +22.2%

Return from IPO: +41.4%

Industry: Health Care

Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca
more less
IPO News for FibroGen
more
IPO Data
IPO File Date 10/01/2014
Offer Price $18.00
Price Range $16.00 - $19.00
Offer Shares (mm) 8.1
Deal Size ($mm) $146
IPO Data
IPO Date 11/13/2014
Offer Price $18.00
Price Range $16.00 - $19.00
Offer Shares (mm) 8.1
Deal Size ($mm) $146
Underwriters
more
Company Data
Headquarters San Francisco, CA
Founded 1993
Employees 337
Website www.FibroGen.com